A M Fein|S H Feinsilver - JoVE Visualize

Showing results (61-70 of 67) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 67 results.

American Journal of Respiratory and Critical Care Medicine|June 14, 2000

Differential patterns of apoptosis in resolving and nonresolving bacterial pneumoniaJ A Kazzaz, S Horowitz, J Xu, et al.

The American Review of Respiratory Disease|May 1, 1984

Proteinase inhibitory function in inflammatory lung disease. I. Acute bacterial pneumoniaW R Abrams, A M Fein, U Kucich, et al.

Chest|June 1, 1992

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineR C Bone, R A Balk, F B Cerra, et al.

American Journal of Respiratory and Critical Care Medicine|May 29, 1998

A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICUA S Multz, D B Chalfin, I M Samson, et al.

The American Review of Respiratory Disease|December 1, 1987

Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VIIS Idell, K Gonzalez, H Bradford, et al.

Critical Care Medicine|June 1, 1995

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study GroupR C Bone, R A Balk, A M Fein, et al.

JAMA|February 12, 1997

Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.

Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 67 results.

American Journal of Respiratory and Critical Care Medicine|June 14, 2000

Differential patterns of apoptosis in resolving and nonresolving bacterial pneumoniaJ A Kazzaz, S Horowitz, J Xu, et al.

The American Review of Respiratory Disease|May 1, 1984

Proteinase inhibitory function in inflammatory lung disease. I. Acute bacterial pneumoniaW R Abrams, A M Fein, U Kucich, et al.

Chest|June 1, 1992

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineR C Bone, R A Balk, F B Cerra, et al.

American Journal of Respiratory and Critical Care Medicine|May 29, 1998

A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICUA S Multz, D B Chalfin, I M Samson, et al.

The American Review of Respiratory Disease|December 1, 1987

Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VIIS Idell, K Gonzalez, H Bradford, et al.

Critical Care Medicine|June 1, 1995

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study GroupR C Bone, R A Balk, A M Fein, et al.

JAMA|February 12, 1997

Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study GroupA M Fein, G R Bernard, G J Criner, et al.

Pageof 7